In a melanoma cell line model, it has been shown that mutant BRAF inhibition may increase DNA damage by downregulation of NHEJ pathway genes, including XRCC6, XRCC5, and PRKDC (Fatkhutdinov et al., 2016). This evidence concerns the gene PRKDC and melanoma.